A formulation of Ketoconazole 2% for treating seborrheic dermatitis called Extina is currently being promoted by Stiefel Laboratories. Stiefel, which is a part of GSK, is promoting Extina as the “first and only ketoconazole foam for scalp, …
August 27th, 2010, by David Pascoe | seborrheic dermatitis
A formulation of Ketoconazole 2% for treating seborrheic dermatitis called Extina is currently being promoted by Stiefel Laboratories. Stiefel, which is a part of GSK, is promoting Extina as the “first and only ketoconazole foam for scalp, …
March 19th, 2010, by David Pascoe | acne treatments, coupons, seborrheic dermatitis, topicals, user reviews
This just published paper details a `new’ product that comprises a slight twist on an old formula. It seems that much of modern research and development involves tweaking existing treatments to see how their efficacy and product lifecycle can be extended.
This new product is known as CLARIFOAM EF Emollient Foam, and is indicated for the topical control of acne vulgaris, acne rosacea …
November 26th, 2009, by David Pascoe | seborrheic dermatitis, steroids
Promiseb Topical Cream has been found to be as effective as desonide cream 0.05% when treating facial dermatitis. This is an exciting finding, especially if the results can be replicated at large in the rosacea / seborrheic dermatitis community. …
August 11th, 2009, by David Pascoe | dermatitis, seborrheic dermatitis, topicals
I was alerted to the launch of a product called Promiseb by a comment left on the Sebclair for Seborrheic Dermatitis post. Since then the news web sites are also covering the press release. Promiseb (probably pronounced Promi-seb) is launching in the U.S. via Promius Pharma, after being licensed from Sinclair Pharma in 2007….
February 23rd, 2009, by David Pascoe | seborrheic dermatitis
This paper summarises the current state of the art for seborrheic dermatitis – research and treatment options. The author mentions recent research that links seborrheic dermatitis with a spore known as Malassezia Globosa. He makes the point that azelaic …